Literature DB >> 22205534

Treatment of glioblastoma multiforme with high doses of carmustine intracavitary, in an infant.

Mónica Rivero-Garvía1, J Márquez-Rivas, A B Rueda-Torres, D Pascual-Argente, G Ramírez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22205534     DOI： 10.1007/s00381-011-1665-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


× No keyword cloud information.
  10 in total

1.  High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.

Authors:  C Dufour; J Grill; A Lellouch-Tubiana; S Puget; P Chastagner; D Frappaz; F Doz; F Pichon; D Plantaz; J C Gentet; M A Raquin; C Kalifa
Journal:  Eur J Cancer       Date:  2006-09-07       Impact factor: 9.162

2.  Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.

Authors:  Javier Márquez-Rivas; Gema Ramirez; Angela Ollero-Ortiz; Jorge Giménez-Pando; Juan Emmerich; Eduardo Quiroga-Cantero; Eloy Rivas; Emilio Gómez-González
Journal:  J Pediatr Hematol Oncol       Date:  2010-07       Impact factor: 1.289

3.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

4.  First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.

Authors:  Hans Christoph Bock; Maximilian Josef Anton Puchner; Frauke Lohmann; Michael Schütze; Simone Koll; Ralf Ketter; Ruediger Buchalla; Nikolai Rainov; Sven R Kantelhardt; Veit Rohde; Alf Giese
Journal:  Neurosurg Rev       Date:  2010-08-13       Impact factor: 3.042

5.  Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.

Authors:  Alessandro Olivi; Stuart A Grossman; Stephen Tatter; Fred Barker; Kevin Judy; Jeffrey Olsen; Jeffrey Bruce; Dana Hilt; Joy Fisher; Steve Piantadosi
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

Review 6.  Experience with irinotecan for the treatment of malignant glioma.

Authors:  James J Vredenburgh; Annick Desjardins; David A Reardon; Henry S Friedman
Journal:  Neuro Oncol       Date:  2008-09-10       Impact factor: 12.300

7.  Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.

Authors:  M Westphal; Z Ram; V Riddle; D Hilt; E Bortey
Journal:  Acta Neurochir (Wien)       Date:  2006-02-17       Impact factor: 2.216

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 9.  Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.

Authors:  Brennan M R Spiegel; Eric Esrailian; Loren Laine; Marc C Chamberlain
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study.

Authors:  Hans Christoph Bock; Joseph Cohnen; Naureen Keric; Sven Rainer Kantelhardt; Alf Giese
Journal:  Acta Neurochir (Wien)       Date:  2011-01-06       Impact factor: 2.216
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.